Retirement Capital Strategies’s Biogen BIIB Stock Holding History

Retirement Capital Strategies’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,380	Closed	-$368K	–	44
2022 Q3	$368K	Hold	1,380	–	–	0.17%	35
2022 Q2	$281K	Hold	1,380	–	–	0.13%	53
2022 Q1	$287K	Hold	1,380	–	–	0.12%	49
2021 Q4	$331K	Hold	1,380	–	–	0.12%	61
2021 Q3	$391K	Hold	1,380	–	–	0.15%	53
2021 Q2	$478K	Hold	1,380	–	–	0.18%	60
2021 Q1	$386K	Hold	1,380	–	–	0.15%	58
2020 Q4	$338K	Hold	1,380	–	–	0.14%	54
2020 Q3	$348K	Hold	1,380	–	–	0.16%	49
2020 Q2	$369K	Hold	1,380	–	–	0.18%	33
2020 Q1	$437K	Hold	1,380	–	–	0.24%	28
2019 Q4	$409K	Hold	1,380	–	–	0.19%	36
2019 Q3	$321K	Hold	1,380	–	–	0.16%	39
2019 Q2	$323K	Hold	1,380	–	–	0.16%	38
2019 Q1	$326K	Hold	1,380	–	–	0.16%	38
2018 Q4	$415K	Hold	1,380	–	–	0.23%	32
2018 Q3	$488K	Buy	+1,380	New	+$475K	0.24%	28

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Retirement Capital Strategies's BIIB Position: Q4 2022 in Review

Retirement Capital Strategies sold out of Biogen (BIIB) in Q4 2022, closing a stake of 1,380 shares — an estimated $368K sold.

Retirement Capital Strategies first reported a position in BIIB in Q3 2018 and held it in 17 quarters. The position peaked at $488K in Q3 2018. 1,031 funds tracked by Wall St. Rank hold BIIB as of Q4 2022.

Retirement Capital Strategies reported no remaining Biogen position as of Q4 2022 after selling out during the quarter.
Retirement Capital Strategies sold 1,380 Biogen shares in Q4 2022, an estimated $368K.
Retirement Capital Strategies first reported a position in Biogen in Q3 2018 and held it in 17 quarters.
Retirement Capital Strategies's Biogen position peaked at $488K in Q3 2018.
1,031 funds tracked by Wall St. Rank held Biogen as of Q4 2022.

Based on Retirement Capital Strategies's 13F filing for Q4 2022, filed 7 Feb 2023.